CAMDI
China Association
for Medical Devices Industry

www.camdi.org

CAMDI01

CURRENT SITUATION AND TREND OF MEDICAL DEVICE MARKETIN CHINA

07

INTRODUCTION07

SERVICES

08

ORGANIZATION CHART

09

BRANCHES

10KEY MEMBERS

11

KEY DEPARTMENT AND THEIR FUNCTIONS

15MEDIA PUBLICITY

16

MEDICAL DEVICES INNOVATION SPECIALIZED IN MEDICALDEVICES INNOVATION INFORMATION

17ASSOCIATION PUBLICATION

www.innomd.org

China Association for Medical Devices Industry

CURRENT SITUATION AND TREND 01
OF MEDICAL DEVICE MARKET IN CHINA

CURRENT SITUATION
AND TREND

OF MEDICAL DEVICE MARKET IN CHINAInternational Medical Device Industry
Development Status•

The output value of the global medical device accounts for 42% of the total value of the pharmaceuticalindustry and the market share of medical device in developed countries is up to 1:1•

In recent years it is highly valued and has become the priority to enhance the bio-pharmaceutical industry andhigh-end device manufacturing industry in developed countries

Data source: Foreign market research agencies, trade association calculation.

TOP 30 PUBLIC MEDICAL DEVICE COMPANIES BY SALES, 2015
Total Revenue,
Last 12 Months

MarketCapitalization

Total Revenue,
Last 12 Months

MarketCapitalization($USDmm, Historical rate)($USDmm, Historical rate)($USDmm, Historical rate)($USDmm, Historical rate)

1 Johnson & Johnson$25,836.0$258,689.9

2 Medtronic plc$23,127.0$98,839.9

16 Abbott Laboratories$5,223.5$59,453.7

17 Olympus Corp.

$4,811.5$11,085.3

3 General Electric Co.

$18,030.0

4 Fresenius Medical Care AG & Co.

$16,982.3$280,909.2

18 Smith & Nephew plc$4,669.0$15,823.2$24,506.3

19 Zimmer Biomet Holdings Inc.

$4,630.9

5 Baxter International Inc.

$19,114.3$16,326.0$17,604.5

20 Terumo Corp.

$4,114.6$10,686.3

6 Siemens AG$14,600.4$79,439.8

21 Toshiba Corp.

$3,509.9$11,367.1

7 Cardinal Health Inc.

$11,395.0$25,685.7

22 Getinge AB$3,432.3$5,457.0

8 Novartis AG$10,485.0$226,977.7

23 Varian Medical Systems Inc.

$3,093.4$7,445.2

9 Koninklijke Philips N.V$10,402.5$23,226.2

24 DENTSPLY International Inc.

$2,781.6$7,368.2

10 Stryker Corp.

$9,818.0$35,742.9

25 Bayer AG$2,672.5$107,846.5

No.

Company Name

No.

Company Name

11 Becton, Dickinson and Co.

$9,410.0$28,298.1

26 Hologic Inc.)$2,640.9$10,559.1

12 Boston Scientific Corp.

$7,272.0$22,269.4

27 Danaher Corp.

$2,505.3$63,641.4

13 Essilor International SA$7,015.3$26,427.6

28 Edwards Lifesciences Corp.

$2,432.5$15,515.6

14 St. Jude Medical Inc.

$5,566.0$17,603.4

29 Intuitive Surgical Inc.

$2,257.3$17,013.9

15 3M Co.

$5,475.0$109,657.2

30 Paul Hartmann AG$2,129.3$1,488.6

Data source: S&P Capital IQ, company data.

02 CAMDI
WWW.CAMDI.ORG

Medical Device Industry Development Status
in China
National Medical Device Output Value in 2015
Sample enterprises above MIIT statistics scale:Industry

Main business income (100 million)

Year-on-Year increase (%)

Medical device
and apparatus manufacture2382.49

10.27

Medical consumables
and medicinal product manufacture

1858.94

10.68

Data source: MIIT

A total of 424.14 billion RMB
Industry-wide output value estimated by the trade association: over 500 billion RMB

The Quantity of Enterprises
By the end of 2015:•

14,151 manufacturers including 5,080 Class I medical device manufacturers, 9,517 Class II medical device
manufacturers and 2,614 Class III medical device manufacturers.

•

186,269 medical device enterprises with licensed management (Class II, III).

Data source: CFDA

Imports and Exports
Medical device total trade amounted to $38.5 billion in 2015•

Imports amounted to $ 17.3 billion, a year-on year increase of 9.8%.

•

Exports amounted to $ 21.2 billion, a year-on year increase of 5.7%.

Data source: China Customs

Distribution of Listed Medical Device Companies in China (As of October 2015)•

41 listed manufacture companies, including 25 in Mainland China (excluding NEEQ) and 16 overseas.

•

In less than 5 years from 2010 to 2015, 24 domestic medical device companies land in the capital markets ofMainland China, Hong Kong and the United States. More than half of the listed medical device companies
contribute to the centralized listings. For a moment a swelling tide of medical devices rises in the capital
market.

The Domestic Medical Device Industry has Huge Development Potential
Developed countries
GPD contributed by the medical industry More than 10%

China
Less than 5%

Device and pharmaceutical markets

About 1:1

About 1:3-4

Global market share

72% (US, Europe, Japan)

About 14%

Domestic market share

70%

30%

Market concentration

High

Low

GPO level

High

Low

CURRENT SITUATION AND TREND 03
OF MEDICAL DEVICE MARKET IN CHINA

All Departments Consider the Medical Device Technology Industry
as the Supporting Priorities
State Council

Promoting the Development of Health Service Industry Guo Fa [2013] No. 40

General Office of the State Council

Outline for the Planning of the National Medical and Health Service System (2015-2020)

National Development and Reform
Commission

Three-Year Action Plan to Improve the Core Competence of Six Manufacturing
Sectors(2015-2017)

State Council

Made in China 2025

General Office of the State Council

Guiding Opinions on Promoting the Healthy Development of the PharmaceuticalIndustry[2016] No.11

Reconstruct the innovation system, build the core competitiveness•Enterprise-oriented, in collaboration with universities and hospitals•

Orderly fund allocation: post subsidy•

Talent scheme and human capital•

Ownership of inventions and patents

Supporting policy on innovative products•

Accelerate registration through green channel•

Expand procurement share and market•

Encourage financial leasing•

Promote the productive service industry like R&D and design and industrial design•

Promote the achievement transformation, strengthen property rights protection•

Preferential fiscal and taxation policies for research expenditures

Speed up industrial upgrading and transformation•

The rapid development of international cooperation and innovation•

Overseas merger•

Integration of technology and capital accelerates•

Industry group and industry chain form: Shenzhen- images, Jiangxi, Jiangsu - polymer supplies,
Suzhou - electronic precision instruments andnanotechnology, Tonglu and Yuhuan (Zhejiang) professional products•Park features reveal•

Enterprises trend to benign differentiation, mergers
and acquisitions rise

04 CAMDI
WWW.CAMDI.ORG

The emergence of new types of operation•

Technology service industry--

Third-party R&D / third-party testing / open laboratory--

Industrial design / consigned development / lease--

Technology transfer / achievement transformation / patent services•

Industrial design / consigned design / consigned processing, OEM / technical sales•

Logistics / third-party operations, maintenance / upgrading•

Hospital engineering / integrated proposal, GPO/ Pharmaceutical Exchange

Investment and M & A continue rising- the new trend of mergers
and acquisitions•

Unlike the past mergers and acquisitions of local medical device companies bymultinational and domestic pharmaceutical listed companies, local outstanding
enterprises kick off overseas mergers and acquisitions, to take the international anddiversified path•

Mindray takes over US ultrasound giant ZONARE. Fosunpharma acquires Israeli
company Alma into the cosmetic device market. MicroPort purchases US Wright
Medical orthopedics, etc.

Cause analysis for the continuous rising of investment and M & A•

Over-crowded segments with smaller market for each one•

The only way for enterprises to grow•One of the most concerned industry segments by private equity and venture capital--•

Short development cycle, fast return on investment and low risk factor

Indirect impact from the new regulations on promoting the division of labor

Recent major policies•

On February 17, 2016, State Council meeting established five policies in order toencourage state-owned research institutions and universities to shift scientific andtechnological achievements to enterprises or other organizations by means of transfer,licensing or evaluation investment.

•

On February 18, 2016, General Office of the State Council issued Guidance on
Accelerating Economic Restructuring and Upgrading through Maker Space’s
Development of Services Entities, which encourages leading enterprises and academic
institutions in key industry fields such as biotechnology, high-end equipment
manufacturing, medicine and health to create national innovation platforms and dual
innovation base and enhances international cooperation.

•

On May 30, 2016 of National Conference on Science and Technology (the third
session), Xi Jinping pointed out that China will become an innovative country until
2020, many important scientific and technical projects and works will be put into
operation. We should focus on major national strategic needs, and strive for coretechnological breakthroughs so that people can enjoy a more comfortable environment,
better health services, more reliable food and drug. We should develop and implement
policies to encourage technological innovation of enterprises, and strengthen the
support efforts of technological innovation to middle and small-sized enterprises.
We should also develop a large number of entrepreneurs and talents who are good atinnovation.

•

In June, 2016, the State Council’s Guidance on Promoting and Regulating Application
and Development of the Big Medical Data (Guo Ban Fa [2016] No. 47) pointed outthat artificial intelligence technology related to health care, 3D printing technology,
medical robots, large medical equipment, health and rehabilitation assistant devices,
wearable devices and related micro sensor devices, and traditional Chinese Medicine
function detection and health care equipment will become the focus of national support.

CURRENT SITUATION AND TREND 05
OF MEDICAL DEVICE MARKET IN CHINA

•

•

•

On May 8, 2015, the State Council announced
the “Made in China 2025”, clearly pointing out
the vigorous promotion of the breakthroughdevelopment in ten key areas including highperformance Medical Device.
On June 4, 2015, Chinese Premier Li Keqiang
chaired a State Council executive meeting,deploying to promote the healthy development ofsocial medical, simplify the review and approvalof medical institutions setup to explore ways likestate-owned establishments run by private owners
and private establishments with governmental
support to establish regional test & examination
centers.
The revised Law of the People's Republic of China
on Promoting the Transformation of Scientificand Technological Achievements was formally
implemented as of October 1, 2015, aiming toincrease and speed up the transformation rate of
the results of universities and research institutions
to business and society, transformation efficiency
and transformation interest allocation mechanism.
Specific measures: public release of R&D
achievement information; transformation of
government functions, the abolition of review andapproval; establish interest mechanism, motivate
researchers’ enthusiasm; strengthen the main roleof enterprises in the transformation of scientificand technological achievements; the government
shall set up a public service platform, with whichcomes suitable tax and policy environment.

•

•

•

CFDA policies•

Special Review and Approval Procedures forInnovative Medical Device (trial) have comeinto force as of March 1, 2014•

On June 1, 2014, CFDA issued the newly
revised Regulation on the Supervision
and Administration of Medical Devices,
encouraging product innovation in enterprises.
Five supporting regulations (CFDA orders
4, 5, 6, 7 and 8) also came effective as of
October 1, 2014.

•

The "Five Rectification" special action for
medical devices•

On July 20, 2015, Regulations on the
Accreditation of Medical Device Clinical Trial
Institutions were published to strengthen thestandardized management of clinical trial
institutions.

The overall effect of newly revised regulations
Positive, a basis for another glorious decade•

CFDA involvement of industrial planning anddevelopment is clear•

Conform to domestic and foreign industry
trends and changes•

Reduce administrative licensing, simplify
administrative procedures•

Accelerate product registration and renewal•

Production enterprises (hospitals) as the
responsible body•Strengthen the process supervision andwithdrawal mechanism•

Refine penalties to make it workable

Policies of NHFPC and NDRC••

Reform of public hospitals - multiple sites
practicing by physicians, grading of diagnosis
and treatment, social capital running hospitals(post approval for private medical institutions)
Carry out Healthy China Cloud Service Plan
- smart medical services, health big dataapplications•

Increase proportion of national medical device
procurement•

Relax large device configuration permits•

Clinical examination item charge policy•

Suspend price limit for high value
consumables•

On May 5, 2015, multiple departments jointly
issued Opinions on Promoting Drug Price
Reform. Since June 1, 2015, it is required toabolish most pharmaceutical governmental
pricing, improve drug procurement
mechanism, strengthen the role of the healthinsurance cost control, strengthen the healthcare conduct supervision and strengthensupervision of pricing behaviors.

The specific impact of the new regulations on theindustry•

Basically establish CFDA as the regulatory
body of the medical device industry, and it
participates in industry and trade development•

Reverse the previous regulatory pattern ofdifficult entry but easy exit•

Overall promote industry innovation anddevelopment•

Promote enterprise collaboration and divisionof work - transformation of part manufacturers
and enterprises, professional R&D design,
emerging and gradually increasing consigned
enterprises, active technological innovation,
increasingly frequent mergers and acquisitions

06 CAMDI
WWW.CAMDI.ORG•

Drug review reform•

On August 18, 2015, the State Council issued
Opinions on Reforming Review & Approval
System for Drugs and Medical Devices (StateCouncil No. [2015] 44), clearly proposing
speeding up the review and approval formuch-needed innovative drugs, reforming
the review and approval method for medical
device, improving review quality control
system, comprehensively exposing review andapproval information of drugs and medical
devices.

The impact of reform on medical device industry•

Delegate part registration and approval
responsibilities to the provincial food and drug
administration departments

to correct unhealthy tendencies in medicine
purchase, consumption and medical service,where the specific rectification of medical
consumable materials became an important
issue. Although concrete implementation
opinions have not been released, the dynamic
monitoring to the rational use of medical
consumable materials will become the norm.
•

The fight against commercial bribery, illegal
invoices and bundles of medical consumablematerials and equipment will become theemphases.

The Change from Business Tax to Value-added
Tax and Two-invoice System•

Circulation is forced to be shortened. Sanmingin Fujian Province stipulates that hospitals
can only sign contracts with manufacturing
enterprises or Chinese general agents.

Increase and establish registration charge
standard for drugs and medical devices,which shall be adjusted every five years; give
appropriate preferential registration fee forsmall innovative enterprises

Affiliating Operations•

Give priority to the core technology patents
and innovative medical devices with significant
clinical value in the review and approval

Price Reduction as a Result of GPO Negotiation•

Improve the adoption rate of international
standards for medical device

•

•

•

Agents at all levels will be thoroughly
investigated by the local drug administrations.
Centralized procurement model of healthreform pilot provinces and cities frequently
downgrades, and prices of medical
consumable materials will inevitably decrease.

High Trustee Fee in Hospital•

Recent Main Policies for Circulation
The Specific Rectification of Medical ConsumableMaterials•

On May 20, 2016, National Health andFamily Planning Commission held theEighteenth Ministerial Meetings in order•

For example, in Henan Province, 80% of
secondary-and tertiary-level hospitals aretrusted with narrowed profit margins ofagents.

Hospitals’ Cutting Down the Number of Suppliersand Distributors of Medical Consumable Materials

CAMDI 07

INTRODUCTIONINTRODUCTION
Founded in 1991, China Association for Medical
Devices Industry (CAMDI) is a non-profit socialorganization with corporative qualification. As anational medical devices industry association, CAMDI
is established on a voluntary basis by organizations andindividuals engaged in the research and development,
production, operation, investment, product testing,certification and consultation, and training in relation to
medical devices.

The purpose of CAMDI is to represent and safeguard
the common interests and legitimate rights of its
members, and to promote the healthy development ofChina’s medical devices industry. CAMDI abides by
the State’s constitution, laws, regulations and policies,
observes social ethnics, and receives guidance andsupervision of the State-owned Assets Supervision
and Administration Commission, receives guidance ofChina Food and Drug Administration.
Currently, CAMDI runs 28 branches and specializedcommittees and has more than 4,000 members.

SERVICESÀÀ Membership Service

ÀÀ Special TrainingÀÀ Information Service

ÀÀ Conference and Exhibition

ÀÀ Certification Consulting

ÀÀ Park Cooperation

ÀÀ Innovation Service

ÀÀ Industrial Self-disciplineÀÀ International Cooperation

08 CAMDI
WWW.CAMDI.ORG

ORGANIZATION
CHART

Member Congress

CouncilStanding Council

Secretariat

China Medical Device Information Periodical Office

Each Branch

Financial Department

OfficeInformation Department

International Cooperation Department

Member Services Department

Technical Regulations Department

CAMDI 09

INTRODUCTION

BRANCHESÀÀ Expert CommitteeÀÀ Dental Equipment and Materials Committee

ÀÀ Standard Operation Committees

ÀÀ Medical Software BranchÀÀ Innovation Services CommitteeÀÀ Nursing products Specialized CommitteeÀÀ Human Resource CommitteeÀÀ Rehabilitation Physiotherapy BranchÀÀ Medical Data Analysis CommitteeÀÀ Surgical Implant Committee

ÀÀ In Vitro Diagnosis (IVD) BranchÀÀ Smart and Mobile Healthcare BranchÀÀ The cardiac and cerebral disease Interventional
therapy industry branchÀÀ Surgical Instrument Committees

ÀÀ Ophthalmic and optical Specialized CommitteeÀÀ Department of orthopedics, biological materials
and equipment Specialized Committee
ÀÀ Medical Device Packaging CommitteeÀÀ Vascular Devices BranchÀÀ Gastrointestinal Endoscopy Innovation andDevelopment BranchÀÀ Medical Polymer Products BranchÀÀ Temperature measurement Specialized CommitteeÀÀ Hygienic Material Committees
ÀÀ Infection and Control Technology Committee
ÀÀ Medical Optical Instrument Committees
ÀÀ Medical Health Care Product Committees
ÀÀ Medical X-ray Equipment BranchÀÀ Aesthetic Plastic Surgical Devices and Materials
Committee
ÀÀ Double Innovation Industrial Cooperation Branch10 CAMDI
WWW.CAMDI.ORG

KEY
MEMBERS

CAMDI 11

INTRODUCTION

KEY DEPARTMENT
AND THEIR FUNCTIONSTechnical Regulations Department
Tel.:+86-10-85659326

E-mail: faguibu@camdi.org; peixh@camdi.org

1. Organizing experts and enterprises to participate in
the research and formulation of national laws andregulations, macroeconomic regulation and control
policies, and industrial policies related to medical
devices

3. Training service(1) Training on medical devices regulations andstandards.
(2) Special training on quality management system.
(3) Business management and skills training.

(1) Giving comments and suggestions in respect ofpolicy and legislation to relevant government
authorities.

4. QMS Certification and Consulting service(2) Actively completing all projects assigned by theState and local government authorities.

5. Organizing academic forums, seminars, businessmeetings and exhibitions on laws and regulations
related to medical devices

2. Organizing relevant parties to formulate and revise
industrial standards for products

the Chairman of CAMDI, Madam Yixin Zhao

the Executive Chairman & CEO of CAMDI, Dr. Feng Jiang

12 CAMDI
WWW.CAMDI.ORG

Member Services Department
Tel.: +86-10-85659323/9296/9268/9394
E-mail: huiyuanbu@camdi.org

1. Member Service
Strengthening contact with the members
and establishing a smooth working network;
listening to and representing the members’requests and safeguarding their lawful rights
and interests; holding professional forums andmeetings; organizing industrial enterprises
participating medical device exhibitions;mailing industry periodicals to the members andproviding publicity platform for them.
2. Member management
Developing members, manage theirmembership, and updating and completingmember registration information; collecting
membership fees, and preparing and issuingmembership certificates.
3. Industrial Self-discipline
Drafting industry regulations and standardizing
enterprises’ behaviors, maintaining faircompetition in the industry and promoting
industry self-discipline.
4. Branches Communication
Coordinating and liaising with the branches andguiding their activities.
5. Proof of issue
Verifying and issuing industrial proof materials
required for enterprise declaration of national
and local programs.

CAMDI 13

INTRODUCTION

International Cooperation Department
Tel.: +86-10-85659296/9268/9394
E-mail: international@camdi.org

1. Liaising with the trade organizations of different
countries and the commercial departments of theirembassies in China, and promoting academic andindustrial cooperation and comunication withforeign countries.
2. Taking an active part in coordinating internationallaws and regulations, and organizing international
cooperation projects.
3. Actively exploring the overseas market, organizing
the member enterprises to participate in worldrenowned exhibitions, and holding forums at
international exhibitions.
4. Organizing and coordinating international businessvisits for domestic enterprises, providing industrial
cooperation opportunities, and providing services
for domestic enterprises to expand overseas markets.

Information Department
Tel.: +86-10-65499360
E-mail: xinxibu@camdi.org

1. Industrial statistics and analysis(1) Organize and implement collection and sorting ofindustry data, establish and improve CAMDI’s database.
(2) Make development analysis and predictive studies
of industry and various fields, prepare industry
development report.
2. Industry development planning
Taking part in the planning of national or regional
development strategies in the field of medical devices andoffering consultation services.
3. Customize consultation service
According to corporate requirements, conduct investigationand survey on products and market and provide oriented
consulting services for pre-market product market status andtrend.

14 CAMDI
WWW.CAMDI.ORG

China Strategic Alliance Officeof Medical Device Innovation(CSAMDI)
Tel.: +86-10-80699031/9033
E-mail: 13621292016@163.com

CSAMDI was proposed and approved by MOST (Ministry of
Science and Technology) in July 2009 and initiated by more than 400
units, including multiple large medical devices enterprises, famous
universities and scientific and research institutions such as Tsinghua
University, Peking University and CAS (Chinese Academy of
Sciences) and social organizations such as CAMDI. Led by enterprises,oriented by market, aimed at improving technology innovation
capacity of medical devices industry and guaranteed by legally binding
agreements, the CSAMDI is developed into an open technologyinnovated organization which emphasizes complementary advantages,
joint development, interest sharing, risk sharing and integration ofindustry, university, research and institution. The tasks of the CSAMDI
include establishing a strategic plan of medical devices sci-techindustry, integrating innovation elements and superior resources inmedical device sci-tech industry, promoting the sci-tech and industrial
innovation of medical devices and assisting MOST to select, review,fund and follow up brilliant researches and development projects,
which amounts to over CNY 200 million regarding state-fund capital.
The CSAMDI Office is settled in the CAMDI where Jiang Feng, theExecutive Chairman & CEO of the CAMDI, serves as the president.
The CSAMDI subordinates 10 branches such as imaging, in vitro
diagnosis and innovative service. With several times of rating as A-levelalliance, it is qualified to recommend proper enterprises to apply forstate funds and plays an increasingly important role in many aspects
such as leading, organizing and servicing national medical devices
industry innovation.

CAMDI 15

INTRODUCTION

MEDIA PUBLICITY
CAMDI website
Website: www.camdi.org

Introduction: CAMDI website contains General Information,
About CAMDI, Window of Membership, News Room,Services, Legislation and Standard, Branches, Publications,Contact Us and other columns.
the CAMDI website is a web service platform facing
the industry, releasing key works, regulatory dynamics,
international business opportunity, industrial informationand exhibition, product, enterprises and other industrial
information, tracking the latest industrial dynamics,
satisfying the demand for enterprise information search,
providing faster and more valuable service for members.

CAMDI WeChat
WeChat of CAMDI was officially launched in January 2016, and it has attracted many
attentions from industrial colleagues since its release. The CAMDI WeChat focuses
on related Chinese policies and regulations, regulatory information of competentauthorities, industrial news, CAMDI dynamics, member information and device
industrial development trend at home and abroad, etc.; based on practicability anddevelopment, trade exchange at home and abroad, upstream-downstream industries
and innovative technology and other information was added; grasping the rhythmof information release, the WeChat will also push industrial important activities andexhibition information.
Follow the CAMDI WeChat, follow the more authoritative and comprehensive
platform, you will receive the latest news and excellent service!

CAMDI WeChat:
Method 1:
scan the QR code left;
Method 2:
click “add” in the WeChat address list and search“CAMDI”.

16 CAMDI
WWW.CAMDI.ORG

MEDICAL DEVICES INNOVATIONCOMPREHENSIVE SERVICE PROVIDER FOR MEDICAL DEVICE INNOVATION
www.innomd.org

www.innomd.org is a new media operated jointly
by several famous domestic innovative service
institutions and technology parks relying on China
Strategic Alliance of Medical Device Innovation(CSAMDI) and Innovation Services Committeeof CAMDI. It is intended to provide high-leveland professional services on medical device
innovation, including product proposal analysis,design or production outsourcing, R&D expenditures
application, product testing and animal (or clinical)
test, product registration, regulatory services andbusiness development at home and abroad.

WeChat official account:
Method 1: scan the QR code up;
Method 2: click “add” in WeChat address list andsearch “innomd” or “Medical Device Innovation”
Sina/Tecent Weibo: @ Medical Devices Innovation
Tel.: +86-512-85665179; +86-512-85667873
E-mail: sally@innomd.org; liss0602@innomd.org

CAMDI 17

INTRODUCTIONASSOCIATIONPUBLICATION

China Medical Device Information
CN: CN11-3700/R
ISSN: ISSN1006-6586
Postal distributing code: 82-256
Responsible Institution:
China Food and Drug Administration
Sponsored by:
China Association for Medical Devices Industry

Founded in 1995, the China Medical Devices
Information is a national and comprehensive medical
device information semimonthly journal in the
charge of CFDA, and sponsored by CAMDI, coorganized by Society of Clinical Medical Engineering,and supported by CIE Life Electronic Society. The
magazine aims to meet the requirements of clinicalengineering management, technical staff and medical
equipment development, spreading the latest medical
device science and technology, market policies
and regulations at home and abroad, promoting thedevelopment of medical device and medical healthin China. In twenty years, the magazine has beendeveloping strongly, playing an active role in respect ofindustrial development information reflection, advanced
technology spreading and market development
guidance, and its target audience covers medical device
R&D, production, marketing, clinic and maintenance.
China Medical Device Information presents highquality print and rich contents with high coverage,
accurate audiences, strong governmental and industrial
background, comprehensive supporting service, andthe average circulation for each issue is 50,000, andthe main audiences are hospital and medical device
enterprises, accounting for 60% and 30% respectively,
while government departments take 6%. The magazine
has been available in second-class and third-classhospitals and over 80% of medical device enterprises
in China. There are decision makers from over 8,000
hospitals and 7,000 medical device enterprises reading
the magazine for each issue.

China Medical Device Information
Periodical Office
Address: Room 1101, Building No. 18, West
Jianwai SOHO, No. 39 Middle Dongsanhuan
Road, Chaoyang District, Beijing
Postcode: 100022

Editorial department: 010-85659236
Media department: 01085659328/65499321/65499319
Fax: 010-85659377

www.innomd.org

CAMDI
Address: Room 1101, Building No. 18, West Jianwai SOHO, No. 39
Middle Dongsanhuan Road, Chaoyang District, Beijing
Postcode: 100022
Tel: +86-10-85659266
Fax: +86-10-85659377
Email: camdi@camdi.org